These observations would indicate that CML cells, particularly LSCs, can be retained in bone marrow by the action of CXCL12, which may be under the control of the cytokine network consisting of G-CSF and other pro-inflammatory cytokines. The gene discussed is CXCL12; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.